ClinVar Genomic variation as it relates to human health
NM_001161352.2(KCNMA1):c.3158A>G (p.Asn1053Ser)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001161352.2(KCNMA1):c.3158A>G (p.Asn1053Ser)
Variation ID: 265313 Accession: VCV000265313.35
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 10q22.3 10: 76891709 (GRCh38) [ NCBI UCSC ] 10: 78651467 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Sep 2, 2017 Oct 20, 2024 Dec 22, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001161352.2:c.3158A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001154824.1:p.Asn1053Ser missense NM_001014797.3:c.2996A>G NP_001014797.1:p.Asn999Ser missense NM_001161353.2:c.3107A>G NP_001154825.1:p.Asn1036Ser missense NM_001271518.2:c.2834A>G NP_001258447.1:p.Asn945Ser missense NM_001271519.2:c.3074A>G NP_001258448.1:p.Asn1025Ser missense NM_001322829.2:c.2993A>G NP_001309758.1:p.Asn998Ser missense NM_001322830.2:c.3086A>G NP_001309759.1:p.Asn1029Ser missense NM_001322832.2:c.2984A>G NP_001309761.1:p.Asn995Ser missense NM_001322835.2:c.3077A>G NP_001309764.1:p.Asn1026Ser missense NM_001322836.2:c.2993A>G NP_001309765.1:p.Asn998Ser missense NM_001322837.2:c.3077A>G NP_001309766.1:p.Asn1026Ser missense NM_001322838.2:c.2531A>G NP_001309767.1:p.Asn844Ser missense NM_002247.2:c.2984A>G NM_002247.4:c.2984A>G NP_002238.2:p.Asn995Ser missense NC_000010.11:g.76891709T>C NC_000010.10:g.78651467T>C NG_012270.1:g.751111A>G - Protein change
- N995S, N999S, N1053S, N1025S, N1026S, N1029S, N1036S, N844S, N945S, N998S
- Other names
- -
- Canonical SPDI
- NC_000010.11:76891708:T:C
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
- Comment on variant
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
KCNMA1 | - | - |
GRCh38 GRCh37 |
920 | 1329 | |
KCNMA1-AS1 | - | - | - | GRCh38 | - | 391 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Jan 3, 2023 | RCV000255423.22 | |
Pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Dec 22, 2023 | RCV000504575.14 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jan 03, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000322055.8
First in ClinVar: Oct 10, 2016 Last updated: Jan 15, 2023 |
Comment:
Published functional studies demonstrate that N995S results in a gain-of-function with markedly increased macroscopic potassium current (Li et al., 2018; Moldenhauer et al., 2020); In … (more)
Published functional studies demonstrate that N995S results in a gain-of-function with markedly increased macroscopic potassium current (Li et al., 2018; Moldenhauer et al., 2020); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); Also known as N1053S using alternate nomenclature; This variant is associated with the following publications: (PMID: 32132200, 32655623, 26195193, 29330545, 30525188, 31152168, 31851553, 32633875, 33043086, 33767182) (less)
|
|
Pathogenic
(Feb 01, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV002497043.18
First in ClinVar: Apr 08, 2022 Last updated: Oct 20, 2024 |
Number of individuals with the variant: 1
|
|
Pathogenic
(Oct 05, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Generalized epilepsy-paroxysmal dyskinesia syndrome
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
de novo
|
Undiagnosed Diseases Network, NIH
Accession: SCV000863433.1
First in ClinVar: Oct 10, 2018 Last updated: Oct 10, 2018 |
Number of individuals with the variant: 1
Clinical Features:
Weak cry (present) , Upgaze palsy (present) , Unilateral ptosis (present) , Umbilical hernia (present) , Speech articulation difficulties (present) , Severe Myopia (present) , … (more)
Weak cry (present) , Upgaze palsy (present) , Unilateral ptosis (present) , Umbilical hernia (present) , Speech articulation difficulties (present) , Severe Myopia (present) , Reduced brain N-acetyl aspartate level by MRS (present) , Recurrent upper respiratory tract infections (present) , Prenatal maternal abnormality (present) , Meconium stained amniotic fluid (present) , Laryngomalacia (present) , Intrauterine growth retardation (present) , Increased axial globe length (present) , Hypoglycemia (present) , Hyperpigmentation of the skin (present) , Hyperbilirubinemia (present) , Hydronephrosis (present) , Generalized joint laxity (present) , Facial palsy (present) , Epicanthus (present) , EEG abnormality (present) , Dry skin (present) , Depressed nasal bridge (present) , Delayed fine motor development (present) , Cyanotic episode (present) , Cranial nerve VI palsy (present) , Cognitive impairment (present) , Cataplexy (present) , Atonic seizures (present) , Asymmetric crying face (present) , Abnormality of the renal collecting system (present) , Abnormality of the nail (present) , Abnormality of the aryepiglottic fold (present) (less)
Age: 0-9 years
Sex: female
Ethnicity/Population group: African American
Tissue: blood
Testing laboratory: HudsonAlpha Clinical Services Lab, LLC,HudsonAlpha Clinical Services Lab, LLC
Date variant was reported to submitter: 2017-08-23
Testing laboratory interpretation: Pathogenic
|
|
Pathogenic
(Dec 22, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Generalized epilepsy-paroxysmal dyskinesia syndrome
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000830549.7
First in ClinVar: Oct 10, 2018 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 995 of the KCNMA1 protein (p.Asn995Ser). … (more)
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 995 of the KCNMA1 protein (p.Asn995Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with epilepsy and/or paroxysomal dyskinesia (PMID: 26195193, 29330545; Invitae). In at least one individual the variant was observed to be de novo. This variant is also known as c.3158A>G (p.Asn1053Ser). ClinVar contains an entry for this variant (Variation ID: 265313). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KCNMA1 protein function. Experimental studies have shown that this missense change affects KCNMA1 function (PMID: 29330545). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Aug 30, 2017)
|
no assertion criteria provided
Method: literature only
|
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000598623.1
First in ClinVar: Sep 02, 2017 Last updated: Sep 02, 2017 |
Comment on evidence:
In a Chinese boy with paroxysmal nonkinesigenic dyskinesia-3 without generalized epilepsy (PNKD3; 609446), Zhang et al. (2015) identified a de novo heterozygous c.3158A-G transition in … (more)
In a Chinese boy with paroxysmal nonkinesigenic dyskinesia-3 without generalized epilepsy (PNKD3; 609446), Zhang et al. (2015) identified a de novo heterozygous c.3158A-G transition in the KCNMA1 gene, resulting in an asn1053-to-ser (N1053S) substitution at a conserved residue. The mutation, which was found by targeted gene sequencing and confirmed by Sanger sequencing, was not found in 500 control samples. Functional studies of the variant and studies of patient cells were not performed. The patient had onset of isolated PNKD at 7 months of age and had mild developmental delay. (less)
|
|
Likely pathogenic
(May 13, 2021)
|
no assertion criteria provided
Method: clinical testing
|
Generalized epilepsy-paroxysmal dyskinesia syndrome
Affected status: yes
Allele origin:
unknown
|
Pediatric Genetics Clinic, Sheba Medical Center
Accession: SCV001712187.1
First in ClinVar: Dec 12, 2021 Last updated: Dec 12, 2021 |
Clinical Features:
Global developmental delay (present) , Seizure (present) , Abnormal facial shape (present)
Secondary finding: no
|
|
Likely pathogenic
(Sep 08, 2002)
|
no assertion criteria provided
Method: research
|
Generalized epilepsy-paroxysmal dyskinesia syndrome
Affected status: yes
Allele origin:
unknown
|
Center of Excellence for Medical Genomics, Chulalongkorn University
Accession: SCV002570056.1
First in ClinVar: Sep 10, 2022 Last updated: Sep 10, 2022 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
De novo BK channel variant causes epilepsy by affecting voltage gating but not Ca(2+) sensitivity. | Li X | European journal of human genetics : EJHG | 2018 | PMID: 29330545 |
De novo KCNMA1 mutations in children with early-onset paroxysmal dyskinesia and developmental delay. | Zhang ZB | Movement disorders : official journal of the Movement Disorder Society | 2015 | PMID: 26195193 |
Text-mined citations for rs886039469 ...
HelpRecord last updated Oct 20, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.
NCBI staff established the molecular definition of 600150.0003 based on supplementary data for the paper by Zhang et al. (PubMed 26195193).